Author's posts
Cancer Will Cost U.S. $5.3 Trillion By 2050, Researchers Estimate
Cancer will cost the global economy more than $25 trillion by 2050, researchers estimate, equivalent to an annual tax of 0.55% on global GDP.
Moderna Hopes To Build On mRNA Tech Used In Its Covid Shots—By Targeting Genetic Diseases
Moderna announced a partnership with Life Edit Therapeutics to tackle “some of the most challenging genetic diseases” using its mRNA technology.
Deadlier Mpox Infections Discovered In People With Advanced HIV
The severe form of the disease carries a 15% mortality rate and is characterized by large and widespread necrotizing skin lesions, researchers wrote.
First RSV Vaccine For Kids—Given To Pregnant Moms—Could Arrive Months Early As FDA Fast-Tracks Review
If approved, Pfizer’s RSV shot for pregnant people could be the first on the market and protect infants from complications from birth through six months.
New Migraine Drug Offers Sufferers Hope Of ‘Fast-Acting Relief’ Via Nasal Spray, Pfizer Says
The FDA is expected to finish its review of the drug by the end of March.
Diabetes Risk Jumps After Covid Infection, Study Finds—Vaccination Seems To Offer Some Protection
Researcher Susan Cheng said Covid could be acting as a “disease accelerator,” amplifying risks for diseases that people might otherwise be likely to develop later on in life.
Male Birth Control Drug Sees ‘Game-Changer’ Trial In Mice—Here’s What You Need To Know
Researchers said the study signals a path towards an on-demand “male pill” that can be taken when needed, with an oral dose taking 30 and 60 minutes to work in mice and fertility returning to normal within a day.
The ‘Last Of Us’ Zombie Fungus Pandemic Is Fiction, But Experts Warn Fungi Are A Major—And Growing—Health Threat
Fungal infections are major killers and claim more lives each year than malaria, HIV and breast cancer, but already limited treatment options are at risk from growing antifungal resistance.
Here’s Why Big Pharma Spends More On Ads Pushing Lower Benefit Drugs, Study Suggests
Johns Hopkins researcher Michael DiStefano said the findings suggest pharma firms are pushing low-value drugs at consumers as part of a “strategy” to drive up patient demand for drugs clinicians could be less likely to prescribe.
Antibiotics Use In Farm Animals Is Growing—Here’s Why It Could Pose A Danger To Humans
The use of antimicrobials in often healthy farm animals promotes drug resistance and could help render infections like gonorrhea, tuberculosis and staph untreatable.
